Since the 1st quarter of 2018 JLLC «Lekpharm» implements new registered drugs
In the first half of 2018 JLLC «Lekpharm» expanded the capabilities of doctors in the treatment of patients with cardiovascular diseases, mastering the release of drugs from the new class - antagonists of angiotensin II receptors (sartans)
JLLC «Lekpharm» informs health professionals about the release of the third dosage in the line of the new drug - Bicard AM (bisoprolol / amlodipine). The company mastered the release of tablets 5 mg / 10 mg № 30.
JLLC «Lekpharm» is awarded with the diploma of the republican contest «The Best Exporter of 2017»
May 23-25, 2018 JLLS «Lekpharm» held a training course "Merchandising and marketing communication in a pharmacy"
JLLC «Lekpharm» received an international certificate of compliance of the site for the production of liquid medicines with GMP requirements, issued after the inspection of the PIC / S (Pharmaceutical Inspection Co-operation Scheme).
On may 16, 2018 JLLC «Lekpharm» held an open day «Trends and results of the development of the pharmaceutical enterprise JLLC «Lekpharm».
April 21, 2018 JLLC «Lekpharm» took part in the festival of Scandinavian walking "Belarus idze", which was held in Minsk in Victory Park.
From 18 to 19 April 2018, in parallel with the visit of the President of Belarus Alexander Lukashenko to Moldova, the Belarusian-Moldovan forum of business and interregional cooperation is held in Chisinau
